CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany is a new market research
publication announced by Reportstack. This report is an essential source of information on and analysis of the
healthcare, regulatory and reimbursement landscape in Germany. It
identifies the key trends in the country’s healthcare market and
provides insights into its demographic, regulatory, and reimbursement
landscape and healthcare infrastructure. Most importantly, the report
provides valuable insights into the trends and segmentation of its
pharmaceutical and medical device markets. It uses data and information
sourced from proprietary databases, secondary research, and in-house
analysis by team members.
Germany’s increasingly elderly population and its associated disease burden are key drivers of its pharmaceutical market. In 2013, the elderly accounted for 27.1% of the total population, expected to increase at Compound Annual Growth Rate (CAGR) of 1.2% to 29.5% in 2020.
In 2008, healthcare expenditure as percentage of Gross Domestic Product (GDP) amounted to 10.7%, which increased to an estimated 11.5% in 2013. In 2011, the government initiated a new plan - Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) - to curb healthcare expenditure.
The pharmaceuticals market was worth $54.7 billion in 2008 and is projected to have reached a value of approximately $65 billion by 2020 at a CAGR of 1.4%. The German medical device market was valued at $18.9 billion in 2008 and is projected to grow at a CAGR of 5.1% to reach $34.4 billion in 2020. These positive growth trends can be primarily attributed to -
- The rising prevalence of chronic disease
- Universal health coverage
- Well established and centralized regulatory procedure
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
- An overview of the pharmaceuticals and medical device markets, consisting of market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market - Novartis, Pfizer, Teva Pharmaceutical, Sanofi and Roche - and profiles and SWOT analyses of the major players in the medical device market - Medtronic, Siemens Healthcare, F. Hoffmann-La Roche, Philips Healthcare and GE Abbott Laboratories
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by enabling you to -
- Develop business strategies by understanding the trends shaping and driving Germany’s healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Germany’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Germany’s healthcare market
Germany’s increasingly elderly population and its associated disease burden are key drivers of its pharmaceutical market. In 2013, the elderly accounted for 27.1% of the total population, expected to increase at Compound Annual Growth Rate (CAGR) of 1.2% to 29.5% in 2020.
In 2008, healthcare expenditure as percentage of Gross Domestic Product (GDP) amounted to 10.7%, which increased to an estimated 11.5% in 2013. In 2011, the government initiated a new plan - Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) - to curb healthcare expenditure.
The pharmaceuticals market was worth $54.7 billion in 2008 and is projected to have reached a value of approximately $65 billion by 2020 at a CAGR of 1.4%. The German medical device market was valued at $18.9 billion in 2008 and is projected to grow at a CAGR of 5.1% to reach $34.4 billion in 2020. These positive growth trends can be primarily attributed to -
- The rising prevalence of chronic disease
- Universal health coverage
- Well established and centralized regulatory procedure
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
- An overview of the pharmaceuticals and medical device markets, consisting of market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market - Novartis, Pfizer, Teva Pharmaceutical, Sanofi and Roche - and profiles and SWOT analyses of the major players in the medical device market - Medtronic, Siemens Healthcare, F. Hoffmann-La Roche, Philips Healthcare and GE Abbott Laboratories
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by enabling you to -
- Develop business strategies by understanding the trends shaping and driving Germany’s healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Germany’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Germany’s healthcare market
To access
full report with TOC, please visit CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
About
Reportstack:
Reportstack
is one of the leading distributors of market research reports in the
world today. We host more than 200,000 research products from the world's top
publication houses. These publications are distributed amongst 12 top industry
verticals and 62 sub verticals, which are then further classified into 257
business categories and 5000 micro markets. The vast selection criterion
provides granular data from the length and breadth of all these industries
delivering Reportstack members with cutting edge research products to
facilitate strategic business decisions.
Contact:
Debora
White
Manager -
Marketing
Ph:
+1-888-789-6604
Reportstack
Market Research
No comments:
Post a Comment